Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis prevalence in the United States commercially insured population.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.
Avonex drug warning letter, severe hypatic injury
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
Overview of the immune system.
New TECFIDERA® (dimethyl fumarate) data show sustained efficacy and long-term safety in a broad range of multiple sclerosis patients
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin.
A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.

Pages